Search Results (6,182)

Objectives: This study evaluates the research landscape of the cyanobacterium Spirulina (recently reclassified as Limnospira), a strategic resource in the nutraceutical, pharmaceutical, and functional food industries. The central objective is to transition from the traditional “superfood” narrative to a structured analysis of its modern therapeutic potential as reflected in current scientific literature. This study employs bibliometric analysis to highlight research trends and thematic directions in Spirulina-related studies, rather than to experimentally validate therapeutic effects. Methods: The investigation employed an exploratory bibliometric analysis of 996 peer-reviewed articles indexed in the Web of Science (2016–2025). Using VOSviewer software, we mapped keyword co-occurrence networks, international collaborations, and institutional clusters to identify dominant thematic directions and emerging research frontiers in biotechnology and medicine. Results: Bibliometric mapping illustrates research trends and thematic associations reported in the scientific literature centered on pathophysiological mechanisms, particularly oxidative stress, inflammation, and hepatoprotection. While often referred to as “microalgae”, Spirulina is biologically a photosynthetic prokaryote with a unique lipid profile characterized by high gamma-linolenic acid (GLA) content, although clinical evidence remains heterogeneous. The analysis highlights a robust regional research hub in the Middle East and North Africa, led by Egypt and Saudi Arabia, in contrast to fragmented inter-continental collaboration. Conclusions: The steady upward trend in publications confirms expanding academic interest in Spirulina as a functional ingredient. However, this study underscores a persistent gap between in vitro bioactivity and standardized clinical validation. These findings provide a roadmap for future biotechnological developments, emphasizing the need for more rigorous, multi-center clinical trials to bridge the “superfood” perception with evidence-based therapeutic applications. Full article

Fermented foods hold a significant position in global culinary traditions, particularly within ethnic and traditional diets. They are widely consumed for their distinctive flavors, textures, and health-promoting attributes. Although extensive research exists on fermentation processes, comprehensive insights into the nutraceutical potential and mechanistic health benefits of these foods remain limited. This review highlights key fermented products traditionally consumed in the north-eastern region of India including Hawaijar, Soibum, Ngari, alongside global counterparts such as Natto, Chongkukjang, Miso, Kefir, Tempeh, Kimchi, Kombucha, and Sauerkraut. These foods are rich in bioactive compounds (phenolics, peptides, organic acids, and exopolysaccharides), probiotic microorganisms, and essential nutrients that collectively contribute to their antioxidant, anti-inflammatory, antidiabetic, and cardioprotective effects. Recent in vitro and in vivo studies demonstrate that regular consumption of such foods may support the prevention and management of chronic conditions, including diabetes, cardiovascular diseases, obesity, gastrointestinal disorders, and neurodegenerative diseases. However, mechanistic studies remain insufficient to fully elucidate the synergistic interactions between microbial metabolites, host metabolism, and gut microbiota modulation. The review therefore emphasizes the biochemical and therapeutic mechanisms underlying ethnic fermented foods, advocating for advanced metabolomic and molecular approaches to validate their health-promoting efficacy. This review provides a timely and integrative perspective by critically evaluating preclinical and clinical evidence, highlighting mechanistic insights, translational gaps, and future research priorities. These insights will support the development of functional food formulations and reinforce the integration of traditional fermented foods into modern dietary strategies for disease prevention and overall well-being. Full article

Background: Intervertebral disc degeneration (IVDD) is driven by the interplay between inflammatory signaling, extracellular matrix (ECM) degradation, and impaired cellular adaptation. Although several nutraceutical compounds have been reported to exert protective effects in IVDD-related models, their multitarget mechanisms within integrated molecular networks remain incompletely characterized. Methods: An in silico framework integrating molecular docking with network-based analyses was employed to evaluate resveratrol, quercetin, melatonin, curcumin, and baicalein against a predefined panel of IVDD-associated targets, within an exploratory in silico framework. Binding affinities and interaction profiles were assessed using molecular docking, followed by protein–protein interaction (PPI) network construction, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses, and hub gene identification. Results: Docking analyses revealed binding energies ranging from −4.59 to −13.25 kcal/mol, with curcumin and quercetin showing plausible docking poses across a subset of selected targets under the applied protocol. Network analysis showed a highly interconnected structure centered on key inflammatory regulators, including NFKB1, IL6, TNF, IL1B, STAT3, and NLRP3, together with ECM-associated components such as ACAN, COL2A1, SOX9, MMP13, and ADAMTS5. Enrichment analyses further suggested significant associations with inflammatory signaling pathways, cytokine regulation, and ECM organization. Conclusions: These findings are compatible with a distributed, multitarget interaction pattern of nutraceutical compounds within IVDD-associated molecular networks. By integrating molecular docking with network-based analyses, this study offers a system-level framework for interpreting previously reported effects within a disease-specific context. Docking-derived interaction patterns should be interpreted as qualitative and exploratory observations, as docking scores represent model-dependent estimates and do not establish comparable pharmacological effects across heterogeneous targets. The results should be considered hypothesis-generating and require experimental validation. Full article

Mango leaves (Mangifera indica), an underutilized residue, represent a promising source of functional proteins with potential applications in emulsion-based delivery systems. Leaf protein concentrate (LPC) was extracted and modified by high-intensity ultrasound (HIU) to enhance its techno-functional properties. The modified protein was subsequently used as a natural emulsifier to develop oil-in-water (O/W) emulsions enriched with Curatella americana leaf extract, a phenolic-rich source of antioxidant bioactive compounds. Ultrasound-assisted emulsification (UAEm) conditions were optimized using a Box–Behnken experimental design, evaluating the effects of protein concentration (0.5, 1, and 1.5%), oil-to-water ratio (1:4, 1:4.5, and 1:5, mL:mL), and sonication time (2.5, 5, and 7.5 min) on droplet size (D_[4,3], µm). The optimized formulation consisted of 1.5% protein, an O/W ratio of 1:4 mL, and a time of 7.5 min, producing an emulsion with a droplet diameter of 7.23 µm. The emulsions exhibited high resistance to storage, pH variation (2–10), ionic strength (100–500 mM NaCl), and thermal treatments up to 50 °C. Additionally, incorporating C. americana extract enhanced thermal stability, photostability, and antioxidant retention under UV exposure, suggesting the formation of reinforcing protein–polyphenol interactions. These findings demonstrate the potential of mango leaf protein as a sustainable emulsifier and protective carrier for sensitive bioactive compounds, supporting its application in functional food and nutraceutical formulations. Full article

This study investigates the influence of agronomic management on the accumulation of bioactive compounds and the antioxidant capacity of Achillea millefolium L., a medicinal species of increasing relevance for pharmaceutical and nutraceutical applications. Different cultivation strategies were applied, including controlled drought stress, foliar fertilization, and inoculation with plant growth–promoting rhizobacteria (PGPR), in order to evaluate their impact on tissue-specific metabolic responses. The total antioxidant capacity (TAC) of flowers and roots was determined using FRAP, DPPH, and ABTS spectrophotometric assays, while metabolite profiling was performed by UHPLC–MS/MS analysis. Clear differences in antioxidant activity were observed among plant organs and cultivation treatments. Flower extracts showed intermediate antioxidant capacity, with FRAP values ranging from 55.86 to 66.55 mg TE g⁻¹ extract and the highest activity consistently recorded for treatment F_010 (addition of K, P fertilizers under water stress conditions and PGPR absence) across all assays. Root extracts exhibited substantially lower antioxidant values (FRAP 19.40–33.69 mg TE g⁻¹), although samples R_000 (no foliar fertilization, under water stress conditions and PGPR absence) and R_100 (no foliar fertilization, under water stress conditions and presence of PGPR) displayed comparatively higher radical scavenging activity. Metabolic profiling revealed a shared presence of caffeic acid derivatives and flavonoids, including mono- and di-caffeoylquinic acids and apigenin-related compounds, with marked quantitative differences among tissues. Overall, the results demonstrate that agronomic practices significantly influence the accumulation and distribution of antioxidant metabolites in A. millefolium L., highlighting the importance of cultivation strategies for optimizing the production of bioactive phytochemicals. Full article

Microbial lipids have emerged as a promising sustainable alternative to plant- and petroleum-derived oils, with applications spanning biofuels, oleochemicals, nutraceuticals, and specialty materials. Significant advances in metabolic engineering and strain development have increased lipid production capacity across diverse microorganisms. Numerous reviews have summarized the biological and metabolic advances in this field, highlighting significant progress in metabolic engineering and strain development that has increased lipid production capacity across diverse microorganisms. However, translating these gains into economically viable industrial processes remains a major challenge. This review examines process engineering strategies for microbial lipid production across the full bioprocessing pipeline, from laboratory-scale strain evolution to industrial-scale operation. We discuss recent developments in adaptive laboratory evolution, systems-guided strain optimization, and robustness engineering, emphasizing their implications for process performance. Key bioprocess parameters—including substrate selection, nutrient limitation strategies, reactor design, oxygen transfer, and process control—are critically evaluated for their impact on lipid yield, productivity, and scalability. Furthermore, downstream processing considerations and techno-economic constraints are analyzed in the context of large-scale implementation. By integrating strain-level innovations with process engineering principles, this review highlights current bottlenecks, emerging solutions, and future directions for achieving efficient and scalable microbial lipid biomanufacturing. Full article

Background/Objectives: Natural multi-component nutraceutical formulations may modulate interconnected pathways involved in metabolic and bone health. This study evaluated, using in vitro models, the effects of a standardized botanical–vitamin formulation on intestinal barrier integrity, osteoblastic activity, and osteoclast differentiation, focusing on intestinal-bone crosstalk, redox-inflammatory signalling, and potential synergistic interactions among components. Methods: A combined in vitro approach using intestinal, osteoblastic, and osteoclastic cell models was applied to assess a formulation containing characterized plant extracts and vitamin D₃. The study evaluated cytocompatibility, intestinal barrier function, cellular uptake, and the modulation of markers related to osteogenesis and osteoclastogenesis, using biochemical, molecular, and enzymatic assays, as well as oxidative stress measurements and synergy analysis. Results: The formulation maintained intestinal barrier integrity and bioavailability without cytotoxicity, promoted osteoblastic differentiation and reduced oxidative stress, while inhibiting osteoclast differentiation and resorptive activity. These effects were associated with modulation of inflammatory and redox-related signalling pathways and showed additive to synergistic interactions among components. Conclusions: These findings support a multi-target nutraceutical approach that can concurrently influence intestinal barrier and bone remodelling in vitro, offering mechanistic evidence for its role in modulating the gut–bone axis, and highlight the need for further studies in advanced models and clinical trials. Full article

Physalis peruviana L., a South American species, has been increasingly cultivated because of its bioactive compounds and high commercial value. This study evaluated the biochemical responses and fruit quality of physalis plants subjected to different water availability regimes (40%, 70%, and 100% of field capacity), followed by recovery periods. The experiment was conducted at São Paulo State University in a randomized block design with split plots. Plants were exposed to different irrigation regimes and subsequently rewatered over a 120-day period. Leaf and fruit analyses showed that water stress at 40% field capacity significantly increased both enzymatic and non-enzymatic antioxidant levels, thereby mitigating oxidative damage, as indicated by lower lipid peroxidation and reduced reactive oxygen species accumulation. However, this defense response was accompanied by marked reductions in fruit yield, fruit number, fresh mass, and fruit quality. Notably, although rewatering reversed several biochemical stress markers at the leaf level, fruit yield and commercial quality did not recover, suggesting irreversible damage to reproductive development during the stress period. These findings indicate that controlled water deficit may enhance antioxidant accumulation, highlighting the potential of stressed plants for pharmaceutical or nutraceutical applications. However, prolonged water stress, even when followed by a recovery period, impairs commercial fruit production. Therefore, irrigation management should be aligned with the intended production objective. Full article

The valorization of agro-industrial by-products is of increasing importance within circular economy strategies. Aronia melanocarpa pomace, a by-product of juice production, represents a valuable source of polyphenols with potential applications in food, nutraceutical, and cosmetic formulations. This study aimed to evaluate the effect of different preservation methods on the polyphenolic composition of Aronia pomace and to optimize accelerated solvent extraction (ASE). Pomace samples were subjected to drying, freeze-drying, freezing (−18 °C), and deep freezing (−80 °C). UAE was applied as a rapid screening method for polyphenol extraction, while ASE was used as an advanced technique for efficient recovery of target compounds. ASE parameters, including temperature (40–120 °C), methanol concentration (40–100%), and number of extraction cycles (1–3), were optimized using response surface methodology (RSM) based on a Box–Behnken design. Qualitative and quantitative analyses were performed using UHPLC–MS and HPLC–DAD. The developed models were statistically significant (p < 0.01) with high coefficients of determination (R² = 0.88–0.97). Temperature had a positive effect on phenolic acid extraction but negatively affected anthocyanins due to thermal degradation. Optimal extraction conditions differed between compound groups: phenolic acids were maximized at 120 °C and 75% methanol (two cycles), while anthocyanins required milder conditions (82 °C, 92% methanol, three cycles). Moreover, our study showed that drying significantly reduced the content of several compounds, particularly anthocyanins, whereas low-temperature methods had minimal impact. The results highlight the importance of tailored extraction strategies and support the sustainable utilization of Aronia pomace as a source of bioactive compounds. Full article

This study investigates the antioxidant properties of several synthetic peptides derived from milk proteins previously identified in milk permeate, a by-product of the dairy industry. The aim of the research is to identify which peptides present in milk permeate are responsible for its antioxidant activity. A comprehensive experimental strategy was employed to evaluate their antioxidant potential, including in silico selection, in vitro free radical scavenging assays and cellular models using Caco-2 and HCT116 cell lines. The peptides were screened using a molecular docking approach for their potential interaction with the Kelch-like ECH-associated protein 1/nuclear factor erythroid 2-related factor 2 (Keap1/Nrf2) pathway, and eight out of twenty-eight were selected and synthesized for further analyses. In vitro, six of the selected peptides demonstrated significant direct antioxidant activity in the DPPH scavenging assay, and two in the ABTS scavenging test. In cellular environments, three peptides (LPAPELGPRQA, LPIIQKLEPQI and NGQVWEESLKRL) effectively protect cells from oxidative stress induced by tert-butyl hydroperoxide, reducing reactive oxygen species production and partially mitigating lipid peroxidation. Further investigation showed that two of them (LPAPELGPRQA and LPIIQKLEPQI) effectively induce the Keap1/Nrf2 pathway, as evidenced by a ∼1.5-fold increase in Nrf2 levels and overexpression of downstream proteins. Permeability studies revealed that these peptides can cross the intestinal monolayer (2–3% in 2 h), suggesting potential systemic effects. Overall, these findings highlight the multifunctional antioxidant properties of the investigated peptides and support their potential application as nutraceuticals or therapeutic agents for oxidative stress-related conditions. Full article

Dietary habits are pivotal in preventing chronic noncommunicable diseases, as vegetable-rich diets provide over 25,000 bioactive phytochemicals that modulate cell-signaling and metabolic pathways. Consequently, nutraceuticals and functional foods are increasingly recognized for their potential to prevent chronic pathologies. Among functional foods, Phaseolus vulgaris L. (common bean) stands out as a critical resource for global nutrition and disease prevention. Beyond its role in food security and environmental sustainability, the common bean offers extraordinary nutrient density, providing a unique “protein plus fiber” package and a source of health-promoting active ingredients. In this review, special emphasis is placed on the bean’s role in preventing or mitigating cardiovascular diseases and cancer, driven by bioactive molecules that modulate metabolic and cell-signaling pathways. Practical evidence of this growing interest is demonstrated by the surge in scientific literature over the last 50 years, as shown by PubMed and Scopus data. By synthesizing data from original research and existing reviews, this work highlights how incorporating common beans into the diet represents a strategic, health-conscious choice with potential therapeutic benefits for human health. Full article

The use of neuroprotective nutraceuticals as a strategy against neurodegenerative diseases such as Parkinson’s disease (PD) has gained considerable traction in recent years. In this review, we highlight ergothioneine (ET)—a naturally occurring thiol/thione derivative abundant in mushrooms—as a promising candidate, given its long half-life, blood–brain barrier penetration, and high bioavailability. Numerous population studies have linked low blood ET levels with increased risk and progression of neurological and other age-related disorders in humans, suggesting that dietary ET may confer neuroprotective benefits. Supporting this, several studies have demonstrated the efficacy of ET treatment in reducing PD-associated molecular damage across various pre-clinical models such as C. elegans, Drosophila, rodent models and human neuronal cultures, leading to marked improvements in disease phenotypes. Here, we summarize some of the proposed mechanisms by which ET may exert neuroprotection in PD, including the reduction of protein aggregation, enhancement of mitochondrial function, mitigation of oxidative stress, and attenuation of apoptosis and neuroinflammation. We also highlight recent clinical trials demonstrating the safety and potential efficacy of ET and propose future research to facilitate the translation of ET into the clinic. Full article